Oxidized lipoproteins activate NF-kappaB binding activity and apoptosis in PC12 cells.
Oxidative stress in the central nervous system may cause oxidation of lipoproteins. The oxidized lipoproteins may in turn damage cellular and subcellular membranes and other biomolecules, leading to tissue injury and cell death. Recently, we have demonstrated that oxidized LDL and VLDL induced cell death in a dose-dependent manner. The present study examined the possible signal transduction cascade leading to cell death by oxLDL and oxVLDL in PC12 cells. Using the electrophoretic mobility shift assay, we found that both oxLDL and oxVLDL activated the binding of NF-kappaB to the consensus sequence in the promoter region of the target genes, followed by apopototic cell death. Resveratrol protects the cells from both the activation of NF-kappa-B/ DNA binding activity and apoptotic cell death. Results indicated that oxidized lipoproteins may serve as an oxidative mediator and may activate apoptosis through a nuclear signalling pathway contributing to the pathology in Alzheimer's disease.
Draczynska-Lusiak
B
B
Department of Pharmacology, University of Missouri, Columbia 65212, USA.
Chen
Y M
YM
Sun
A Y
AY
D000818:Animals; D000975:Antioxidants / Q000494:pharmacology*; D017209:Apoptosis / Q000502:physiology*; D016384:Consensus Sequence; D008077:Lipoproteins, LDL / Q000502:physiology*; D008079:Lipoproteins, VLDL / Q000502:physiology*; D016328:NF-kappa B / Q000378:metabolism*; D010084:Oxidation-Reduction; D016716:PC12 Cells; D011401:Promoter Regions, Genetic; D051381:Rats; D000077185:Resveratrol; D015398:Signal Transduction / Q000187:drug effects*; D013267:Stilbenes / Q000494:pharmacology
D000975:Antioxidants; D008077:Lipoproteins, LDL; D008079:Lipoproteins, VLDL; D016328:NF-kappa B; D013267:Stilbenes; D000077185:Resveratrol